Pituitary Stalk Interruption Syndrome from Infancy to Adulthood: Clinical, Hormonal, and Radiological Assessment According to the Initial Presentation

PLoS One. 2015 Nov 12;10(11):e0142354. doi: 10.1371/journal.pone.0142354. eCollection 2015.

Abstract

Background: Patients with pituitary stalk interruption syndrome (PSIS) are initially referred for hypoglycemia during the neonatal period or growth retardation during childhood. PSIS is either isolated (nonsyndromic) or associated with extra-pituitary malformations (syndromic).

Objective: To compare baseline characteristics and long-term evolution in patients with PSIS according to the initial presentation.

Study design: Sixty-seven patients with PSIS were included. Data from subgroups were compared: neonates (n = 10) versus growth retardation patients (n = 47), and syndromic (n = 32) versus nonsyndromic patients (n = 35).

Results: Neonates displayed a more severe hormonal and radiological phenotype than children referred for growth retardation, with a higher incidence of multiple hormonal deficiencies (100% versus 34%; P = 0.0005) and a nonvisible anterior pituitary lobe (33% versus 2%; P = 0.0017). Regular follow-up of growth might have allowed earlier diagnosis in the children with growth retardation, as decreased growth velocity and growth retardation were present respectively 3 and 2 years before referral. We documented a progressive worsening of endocrine impairment throughout childhood in these patients. Presence of extra-pituitary malformations (found in 48%) was not associated with more severe hormonal and radiological characteristics. Growth under GH treatment was similar in the patient groups and did not vary according to the pituitary MRI findings.

Conclusions: PSIS diagnosed in the neonatal period has a particularly severe hormonal and radiological phenotype. The progressive worsening of endocrine impairment throughout childhood justifies periodic follow-up to check for additional hormonal deficiencies.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Female
  • Growth Disorders / blood
  • Growth Disorders / drug therapy
  • Hormone Replacement Therapy
  • Hormones / blood
  • Hormones / deficiency
  • Hormones / therapeutic use
  • Humans
  • Infant
  • Infant, Newborn
  • Longitudinal Studies
  • Magnetic Resonance Imaging
  • Male
  • Pituitary Diseases / blood
  • Pituitary Diseases / diagnosis*
  • Pituitary Diseases / drug therapy
  • Pituitary Gland / abnormalities*
  • Pituitary Gland / diagnostic imaging
  • Pituitary Gland, Anterior / abnormalities*
  • Pituitary Gland, Anterior / diagnostic imaging
  • Radiography
  • Regression Analysis
  • Retrospective Studies
  • Syndrome
  • Treatment Outcome

Substances

  • Hormones

Grants and funding

The authors have no support or funding to report.